The Global Breast Cancer Burden: Variations in Epidemiology and Survival

Hortobágyi, Gabriel N.; Salazar, Jaime de; Pritchard, Kathleen I.; Amadori, Dino; Haidinger, Renate; Hudis, Clifford A.; Khaled, Hussein; Liu, Mei Ching; Martín, M Carmen; Namer, M.; O’Shaughnessy, Joyce; Shen, Zhen; Albain, Kathy S.

doi:10.3816/cbc.2005.n.043

Cited by 481 publications

(333 citation statements)

References 44 publications

Supporting

Mentioning

322

Contrasting

Unclassified

Order By: Relevance

“…Although the incidence of breast cancer has increased globally over the last several decades (Hortobagyi et al, 2005;Anderson and Jakesz, 2008;Porter, 2008), the greatest increase has been reported in Asian countries (Green and Raina, 2008). It is expected that in coming decades, Asia would account for majority of new breast cancer patients diagnosed globally.…”

Section: Introductionmentioning

confidence: 99%

Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India

Dogra¹,

Doval²,

Sardana³

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India

Dogra¹,

Doval²,

Sardana³

et al. 2015

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…1 Epirubicin (EPI), belonging to the anthracyclines, is one of the most effective drugs against breast cancer. At present, nearly half of the chemotherapy regimens of breast cancer contain EPI.…”

Section: Introductionmentioning

confidence: 99%

Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development

Sun¹,

Chen²,

Wang³

et al. 2011

Autophagy

164

142

View full text Add to dashboard Cite

show abstract

“…Today it is the most prevalent cancer among women worldwide, both in developed and developing countries (GLOBOCAN, 2008). It is predicted that the incidence in 2050 will reach almost 3.2 million (Hortobagyi et al, 2005;McCormack and Boffetta, 2011;Youlden et al, 2012). The standardized incidence rates range from 19.3 per 100,000 women in Eastern Africa to 89.9 per 100,000 women in Western Europe.…”

Section: Introductionmentioning

confidence: 99%

Risk Factors of Breast Cancer in Kyzylorda Oblast of Kazakhstan: a Case-Control Study

Toleutay¹,

Резник²,

Kalmatayeva³

et al. 2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Background: Breast cancer in Kazakhstan and its Kyzylorda oblast is the most prevalent cancer in women and features increasing trends of incidence. The aim of study was to reveal risk factors for breast cancer among women of Kyzylorda oblast of Kazakhstan. Materials and Methods: A hospital-based case-control study was conducted at Kyzylorda oblast Oncology Center, including 114 cases of breast cancer and 196 controls. Binary logistic regression analysis was performed. Results: Social and behavioral risk factors for breast cancer were evaluated, among which unfavorable living conditions, chronic stress, unilateral breastfeeding, breastfeeding less than 3 months and over 2 years, abortions, and hereditary predisposition were found to be related with increased breast cancer risk. Breastfeeding for 6-24 months was found to be protective. Conclusions: The findings may have significant impact on activity planning aimed towards breast cancer reduction among women in Kazakhstan.

show abstract

The Global Breast Cancer Burden: Variations in Epidemiology and Survival

Cited by 481 publications

References 44 publications

Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India

Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India

Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development

Risk Factors of Breast Cancer in Kyzylorda Oblast of Kazakhstan: a Case-Control Study

Contact Info

Product

Resources

About